You are here: Industry Insights > merger

News List

China Jo-Jo Drugstores Completes Redomiciliation Merger prnasia
August 02, 2021
China Jo-Jo Drugstores, Inc. announced that the redomiciliation merger to redomicile the Company as a Cayman Islands company has been completed.
GC LabCell and GC Cell Merge americanpharmaceuticalreview
July 19, 2021
GC LabCell and GC Cell announced that they have entered into a definitive merger agreement to combine in an all-stock transaction.
China Biologic Announces Completion of Going Private Transaction prnasia
April 21, 2021
China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger with CBPO Group Limited, a wholly owned subsidiary of CBPO Holdings Limited , pursuant to ...
International trade officials to review impact of pharma mergers europeanpharmaceuticalreview
March 19, 2021
The Federal Trade Commission will work with international regulators to review the effects of pharma mergers and update approaches to analysing them.
Aytu BioScience, Neos Therapeutics Announce Merger Agreement americanpharmaceuticalreview
December 31, 2020
Aytu BioScience and Neos Therapeutics have entered into a definitive merger agreement pursuant to which Neos will merge with a wholly owned subsidiary of Aytu in an all-stock transaction.
Cytocom and Cleveland Biolabs Merge contractpharma
October 22, 2020
Cytocom Inc. and Cleveland BioLabs Inc. have entered into a definitive merger agreement to combine their businesses in an all-stock transaction.
Kymos and Prolytic Merge contractpharma
September 30, 2020
Become Kymos Group, a pan-European CRO dedicated to innovative pharmaceuticals.
Jubilant Biosys Merges with Jubilant Chemsys contractpharma
July 30, 2020
Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Life Sciences Limited, has completed a merger with its sister company Jubilant Chemsys Limited, based in Noida, India.
NeuroBo Pharmaceuticals complete Gemphire merger pharmaceutical-technology
January 14, 2020
NeuroBo Pharmaceuticals has completed its previously announced combination with Gemphire Therapeutics.The combined unit will operate as NeuroBo Pharmaceuticals with NeuroBo shareholders holding a 96.24% stake in the firm.
NeuroBo Pharmaceuticals and Gemphire Therapeutics Complete Merger firstwordpharma
January 11, 2020
NeuroBo will focus on advancing the company's clinical-stage pipeline for neurodegenerative diseases.

Previous page 1 2 3 4 Next page